Multiple non-ossifying fibromatosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2029
Who is this for?
Show terms as
20Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multiple non-ossifying fibromatosis, also known as multiple non-ossifying fibromas or Jaffe-Campanacci syndrome, is a rare skeletal disorder characterized by the presence of multiple non-ossifying fibromas (fibrous cortical defects) in the long bones. Non-ossifying fibromas are benign fibrous lesions that occur in the metaphyseal regions of bones, most commonly in the lower extremities (femur and tibia), though they can also affect the upper extremities. While solitary non-ossifying fibromas are relatively common incidental findings in children and adolescents, the occurrence of multiple lesions is rare and may be associated with extraskeletal manifestations. In Jaffe-Campanacci syndrome, multiple non-ossifying fibromas are accompanied by café-au-lait skin spots, intellectual disability in some cases, hypogonadism or cryptorchidism, ocular anomalies, and cardiovascular malformations. The skeletal lesions may weaken the bone cortex, predisposing affected individuals to pathological fractures. The condition typically presents during childhood or adolescence when the lesions are discovered incidentally on radiographs or following a pathological fracture. Treatment is primarily symptomatic and supportive. Small, asymptomatic non-ossifying fibromas generally require only observation, as many resolve spontaneously with skeletal maturation. Larger lesions that cause pain, threaten structural integrity, or result in pathological fractures may require surgical curettage and bone grafting. Regular orthopedic monitoring is recommended to assess lesion progression. The extraskeletal features, when present, are managed by appropriate specialists. The relationship between this condition and neurofibromatosis type 1 (NF1) has been debated, as some patients with multiple non-ossifying fibromas and café-au-lait spots may ultimately meet diagnostic criteria for NF1.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Multiple non-ossifying fibromatosis.

View clinical trials →

No actively recruiting trials found for Multiple non-ossifying fibromatosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Multiple non-ossifying fibromatosis community →

Specialists

20 foundView all specialists →
BM
Brigitte C Widemann, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 18 active trials
BM
Brigitte C. Widemann, MD
BETHESDA, MD
Specialist
PI on 6 active trials
PM
Prashant Chittiboina, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 7 active trials
DM
Donald Gilbert, MD MS
Cincinnati, Ohio
Specialist

Rare Disease Specialist

PI on 1 active trial
VP
Vanessa Merker, PhD
Boston, Massachusetts
Specialist

Rare Disease Specialist

PI on 3 active trials
SP
Scott Plotkin, MD, PhD
BUFFALO, NY
Specialist
PI on 3 active trials
DM
Dusica Babovic-Vuksanovic, MD
ROCHESTER, MN
Specialist
PI on 1 active trial
JM
John D Heiss, M.D.
BETHESDA, MD
Specialist
PI on 6 active trials
QL
Qingfeng Li
Shanghai
Specialist

Rare Disease Specialist

PI on 1 active trial572 Multiple non-ossifying fibromatosis publications
RM
Richard R Anderson, MD
Specialist
PI on 4 active trials
TM
Tiago R Marques, MD
Specialist
PI on 2 active trials
SP
Staci M Peron, Ph.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 8 active trials
JB
Jaishri Blakeley
BALTIMORE, MD
Specialist
PI on 1 active trial10 Multiple non-ossifying fibromatosis publications
KP
Kristina Hardy, PhD
Specialist
PI on 1 active trial
BP
Bartlett D. Moore, PhD
HOUSTON, TX
Specialist
PI on 1 active trial
DM
Daniel Morgenstern
Toronto, Ontario
Specialist

Rare Disease Specialist

PI on 1 active trial1 Multiple non-ossifying fibromatosis publication
SM
Stergios Moschos, MD
Chapel Hill, North Carolina
Specialist

Rare Disease Specialist

PI on 3 active trials
MM
Min-Gul Kim, MD
Specialist
PI on 2 active trials
EM
Erika Santos Horta, MD
OKLAHOMA CITY, OK
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Multiple non-ossifying fibromatosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Multiple non-ossifying fibromatosisForum →

No community posts yet. Be the first to share your experience with Multiple non-ossifying fibromatosis.

Start the conversation →

Latest news about Multiple non-ossifying fibromatosis

No recent news articles for Multiple non-ossifying fibromatosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Multiple non-ossifying fibromatosis

What is Multiple non-ossifying fibromatosis?

Multiple non-ossifying fibromatosis, also known as multiple non-ossifying fibromas or Jaffe-Campanacci syndrome, is a rare skeletal disorder characterized by the presence of multiple non-ossifying fibromas (fibrous cortical defects) in the long bones. Non-ossifying fibromas are benign fibrous lesions that occur in the metaphyseal regions of bones, most commonly in the lower extremities (femur and tibia), though they can also affect the upper extremities. While solitary non-ossifying fibromas are relatively common incidental findings in children and adolescents, the occurrence of multiple lesio

At what age does Multiple non-ossifying fibromatosis typically begin?

Typical onset of Multiple non-ossifying fibromatosis is childhood. Age of onset can vary across affected individuals.

Which specialists treat Multiple non-ossifying fibromatosis?

20 specialists and care centers treating Multiple non-ossifying fibromatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.